Passionate advocate for doing the right thing. Firm proponent of harnessing science to benefit humankind. Heartfelt believer that inclusion benefits us all.
IP is complicated – which is why we need more education and to tell the story about why #IP matters to #biotech innovation, says @NancySTravis at #BIO2023
Inspiring short films about groundbreaking treatments & patient stories screen at #BIO2023 in Boston. Importance of diversity in clinical trials and living with hemophilia just two compelling topics.
#NEWS: AdvaMed is proud to welcome @JNJMedTech’s Ashley McEvoy as the new Chairman of the Board. Her priorities as Chair include building a resilient healthcare system, driving digital transformation in #medtech, and increasing diversity in the industry. https://t.co/54d0SyMP4Q
The most inspirational kid on the planet (at least in my world) and his two brothers who’ve been with him through thick and thin this year got to meet the most inspirational athlete on the planet, @HamlinIsland. What a kind, down-to-earth soul. Thanks for the pep talk, Damar.
BIO is excited to announce Dr. Annie Tsong, Chief Strategy and Product Officer at @Amyris, as this year’s Rosalind Franklin Award recipient! Her work helps save the planet by developing biotech-based alternatives to ingredients from limited or vulnerable natural sources.
“I am a fan of accelerated approvals,” says @US_FDA’s Robert Califf.
Today, #BIO2022 closes out with a timely and critical discussion on the importance of accelerated approvals in bringing life-changing innovations to patients. Hosted by @DrMichelleBIO.
We've enjoyed bringing the biotech community together again to celebrate their life saving work that allowed us to gather in person. Thanks to all who attended #BIO2022!
"Our member companies, large and small, have done the impossible, creating vaccines faster than ever before, with the highest stakes in a century for global health." – Opening remarks from Paul Hastings, BIO's Chair and CEO of Nkarta Therapeutics. #BIO2022